ATE483714T1 - Podophyllotoxine als antiproliferative mittel - Google Patents

Podophyllotoxine als antiproliferative mittel

Info

Publication number
ATE483714T1
ATE483714T1 AT02791768T AT02791768T ATE483714T1 AT E483714 T1 ATE483714 T1 AT E483714T1 AT 02791768 T AT02791768 T AT 02791768T AT 02791768 T AT02791768 T AT 02791768T AT E483714 T1 ATE483714 T1 AT E483714T1
Authority
AT
Austria
Prior art keywords
podophyllotoxins
antiproliferative agents
antiproliferative
agents
production
Prior art date
Application number
AT02791768T
Other languages
English (en)
Inventor
Gerhard Gaedicke
Holger Lode
Wolfgang Wrasidlo
Original Assignee
Universitaetsklinikum Charite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7708614&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE483714(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Universitaetsklinikum Charite filed Critical Universitaetsklinikum Charite
Application granted granted Critical
Publication of ATE483714T1 publication Critical patent/ATE483714T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT02791768T 2001-12-03 2002-12-03 Podophyllotoxine als antiproliferative mittel ATE483714T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10160515 2001-12-03
PCT/EP2002/013669 WO2003048166A1 (en) 2001-12-03 2002-12-03 Podophyllotoxins as antiproliferative agents

Publications (1)

Publication Number Publication Date
ATE483714T1 true ATE483714T1 (de) 2010-10-15

Family

ID=7708614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02791768T ATE483714T1 (de) 2001-12-03 2002-12-03 Podophyllotoxine als antiproliferative mittel

Country Status (10)

Country Link
US (1) US7582778B2 (de)
EP (2) EP1451193B1 (de)
JP (2) JP4527978B2 (de)
AT (1) ATE483714T1 (de)
AU (1) AU2002358086B2 (de)
CA (1) CA2468479C (de)
DE (1) DE60237915D1 (de)
DK (1) DK2327705T3 (de)
ES (2) ES2545393T3 (de)
WO (1) WO2003048166A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
JP4527978B2 (ja) * 2001-12-03 2010-08-18 ウニベルジテートスクリーニクム シャリテー デア フンボルト−ウニベルジテート ツー ベルリン テクノロジー トランスファーステラ ポドフィロトキシン
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
US20110191868A1 (en) 2008-04-10 2011-08-04 Massachusetts Institute Of Technology Methods for identification and use of agents targeting cancer stem cells
US20100256385A1 (en) * 2009-04-02 2010-10-07 Allergan, Inc. Prostaglandin e receptor antagonists
JP5727000B2 (ja) * 2010-04-16 2015-06-03 ツェルアクト ファーマ ゲーエムベーハー 腫瘍の処置のためのエポトシドのアナログ
CN102070645B (zh) * 2011-01-07 2015-04-22 兰州大学 一种脱氧鬼臼毒素类化合物及其制备与应用
US10106778B2 (en) 2012-11-08 2018-10-23 Whitehead Institute For Biomedical Research Selective targeting of cancer stem cells
GB2513299A (en) 2013-03-12 2014-10-29 Cellact Pharma Gmbh Biomedizinzentrum Compounds for targeting cancer stem cells
US10398672B2 (en) 2014-04-29 2019-09-03 Whitehead Institute For Biomedical Research Methods and compositions for targeting cancer stem cells
EP3211091A1 (de) * 2016-02-24 2017-08-30 CellAct Pharma GmbH Verfahren zur diagnose von mit etoposid-prodrug behandelbarem krebs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975278A (en) 1988-02-26 1990-12-04 Bristol-Myers Company Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
NZ225599A (en) * 1987-08-04 1991-09-25 Bristol Myers Co Antibody-enzyme conjugates and combinations with prodrugs for the treatment of tumour cells
ZA886810B (en) * 1987-12-18 1989-08-30 Bristol Myers Co Epipodophyllotoxin glucoside 4'-acyl derivatives
US5411947A (en) 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
DE3935016A1 (de) 1989-10-20 1991-04-25 Behringwerke Ag Glycosyl-etoposid-prodrugs, verfahren zu ihrer herstellung und ihre anwendung in kombination mit funktionalisiertem tumorspezifischen enzym-konjugaten
US6610841B1 (en) 1997-12-18 2003-08-26 Gilead Sciences, Inc. Nucleotide-based prodrugs
JP4115514B2 (ja) 1991-10-23 2008-07-09 キャンサー・リサーチ・キヤンペーン・テクノロジー・リミテツド Ｃｂ １９５４およびその類似体を細胞障害性の形態に還元するための細菌のニトロリダクターゼ
DE4236237A1 (de) * 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
US5605976A (en) 1995-05-15 1997-02-25 Enzon, Inc. Method of preparing polyalkylene oxide carboxylic acids
CA2264227A1 (en) 1996-09-27 1998-04-02 Raymond A. Firestone Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells
JP4527978B2 (ja) * 2001-12-03 2010-08-18 ウニベルジテートスクリーニクム シャリテー デア フンボルト−ウニベルジテート ツー ベルリン テクノロジー トランスファーステラ ポドフィロトキシン

Also Published As

Publication number Publication date
EP1451193B1 (de) 2010-10-06
AU2002358086A1 (en) 2003-06-17
EP1451193A1 (de) 2004-09-01
ES2545393T3 (es) 2015-09-10
JP4527978B2 (ja) 2010-08-18
EP2327705A1 (de) 2011-06-01
DE60237915D1 (en) 2010-11-18
AU2002358086B2 (en) 2009-06-04
CA2468479C (en) 2010-04-27
ES2354065T3 (es) 2011-03-09
US20060293254A1 (en) 2006-12-28
JP2005517645A (ja) 2005-06-16
JP5302862B2 (ja) 2013-10-02
WO2003048166A1 (en) 2003-06-12
CA2468479A1 (en) 2003-06-12
DK2327705T3 (en) 2015-08-24
US7582778B2 (en) 2009-09-01
EP2327705B1 (de) 2015-05-27
JP2010120943A (ja) 2010-06-03

Similar Documents

Publication Publication Date Title
NO20091976L (no) Nye forbindelser
ATE451349T1 (de) Neue verbindungen als entzündungshemmende, immunmodulierende und antiproliferative mittel
BR0212250B1 (pt) produto de cuidado pessoal.
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
DE60234264D1 (de) Spiro-hydantoin-verbindungen, die sich als entzündungshemmende mittel eignen
BR0216099B1 (pt) "conjunto de desgaste".
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
BR0202485B1 (pt) escada rolante ou esteira rolante.
ITTO20010883A0 (it) Pista sospesa.
DE50208918D1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
DK1385518T3 (da) Benzimidazolon-forbindelser
ATE483714T1 (de) Podophyllotoxine als antiproliferative mittel
DE60210598D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
ATE527280T1 (de) Fluoreszentprotein und chromoprotein
ATE332902T1 (de) 3,7-diazabicycloc3.3.1)-formulierungen als antiarrhythmika
BR0206922A (pt) Compostos orgânicos
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
DE60324753D1 (de) Antiallergische, antibakterielle und rötungsmindernde Augenzusammensetzung
ATE335766T1 (de) Antikörper gegen caspase-8, ihre herstellung und verwendung
DZ3441A1 (fr) Nouvelles phenylpiperazines.
ATE405668T1 (de) Exopolysaccharidproduktion
DE50310743D1 (de) Wässrige formulierungen von (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4- trifluorbutan-1-sulfonat
NO20040913L (no) Nye 2,4-diaminotiazolderivater
ATE334692T1 (de) Kombination von arnica, ruscus und menthol
ITRM20020134A0 (it) Carrucola superleggera autofrenante 180 ab.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties